Proactive Investors - Run By Investors For Investors

Harvey Nash reports strong growth in 2017 despite Brexit uncertainty

Harvey Nash Group plc (LON:HVN) chief executive Albert Ellis and group finance director Mark Garratt caught up with Proactive Investors following their 2017 trading update.

The group reported a 6% increase in gross profit in the UK & Ireland in the year to January 31, supported by improving demand in the second half for technology recruitment.

 
Meet Alliance Pharma plc, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full HVN profile View Profile

Harvey Nash Group plc Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use